With inflation pressures easing in many regions and central banks rethinking their next moves, cash flows and valuation are back in focus for patient value hunters. Instead of chasing headlines around energy prices, interest rates, or geopolitics, the Undervalued Stocks Based On Cash Flows screener highlights companies where current prices sit below SWS DCF fair value estimates, yet cash flow potential still looks promising. That combination can appeal if you want exposure to steady business fundamentals without paying up for excitement. This article walks through three notable stocks from the screener to help sharpen your watchlist.

Round One (TSE:4680)

Overview: Round One is a Japan based operator of indoor leisure complexes, offering bowling, arcade games, karaoke, billiards and multi sport “Spo Cha” facilities across its venues.

Operations: Round One generates most of its revenue in Japan at ¥108,689 million, with a sizeable contribution from the United States at ¥79,662 million and a small amount from other regions at ¥1,196 million.

Market Cap: ¥268.5b

Round One stock appears on the cash flow screener because the shares trade below the Simply Wall St DCF fair value estimate, and analysts also see upside based on their target prices. Earnings and revenue are both forecast to grow, with return on equity around 20.1%, which indicates efficient use of capital. The company has a long operating history in leisure entertainment and a seasoned management team and board, although less than half of directors are independent. One key consideration is that 100% of its liabilities come from higher risk non deposit funding, which adds financial risk that investors may wish to weigh against the company’s growth potential and the current valuation gap.

Round One stock looks like a classic valuation gap story, with cash flows and return on equity pointing one way while the balance sheet risk tells another. It is therefore worth scanning the DCF valuation analysis for Round One to see what might be hiding beneath the surface.

Chugai Pharmaceutical (TSE:4519)

Overview: Chugai Pharmaceutical is a Japan based drug company that researches, develops, manufactures and sells prescription medicines worldwide, with a focus on oncology and complex biologic therapies for conditions such as cancer, autoimmune and rare diseases.

Operations: Chugai Pharmaceutical generates essentially all of its ¥1,291.2b in revenue from pharmaceuticals, with reported sales centered on Japan and Switzerland.

Market Cap: ¥12,381.1b

Chugai Pharmaceutical stands out on the cash flow screener because it combines a portfolio of high value biologic drugs with strong profitability, including a net margin around 35% and solid recent earnings growth. However, the stock trades well below the Simply Wall St DCF estimate and below analyst consensus fair value. The company’s tight focus on oncology and complex antibodies has supported earnings strength, but it also means heavy reliance on a handful of blockbusters that will eventually face patent and pricing pressure. In addition, its close tie to Roche and recent decisions to drop some R&D projects result in a quality business with clear growth drivers but also real concentration risk that deserves a closer look.

Chugai Pharmaceutical’s high margin drug portfolio and cash generation appear to be at odds with its current share price. This raises a simple question for investors: what is the market missing in the 4 key rewards and 1 important warning sign?

Taiyo Yuden (TSE:6976)

Overview: Taiyo Yuden is a Japan based electronics manufacturer that supplies key passive components such as multilayer ceramic capacitors, inductors, RF and high frequency devices, and aluminum electrolytic capacitors for use in cars, smartphones, wearables and other electronic products worldwide.

Operations: Taiyo Yuden generates all of its ¥355,341 million in revenue from its Electronic Components Business, with sales spread across China, Japan, Europe, Taiwan, Hong Kong, North America and other regions.

Market Cap: ¥2,524.8b

Taiyo Yuden appears on a cash flow based screen because the stock trades about 19.6% below the Simply Wall St fair value estimate. Earnings are forecast to grow around 30% a year and revenue about 10% a year, supported by new products such as high capacitance automotive grade MLCCs and compact power inductors. At the same time, the current net margin is a modest 4.2%, earnings over the past five years declined sharply, the share price has been highly volatile and all liabilities come from higher risk borrowing, so this is not a low risk story. For investors willing to weigh that trade off, Taiyo Yuden presents an example of a company with growth forecasts, product momentum and a valuation gap that may warrant closer inspection.

Taiyo Yuden’s growth forecasts and product momentum look like they are pulling away from its modest 4.2% net margin and higher risk borrowing profile, so the analyst forecasts for Taiyo Yuden could be the missing clue to whether that gap closes or widens next.

The three stocks covered here are only a starting point, as the full Undervalued Stocks Based On Cash Flows screen has identified 58 more companies via the Undervalued Stocks Based On Cash Flows screener that pair discounted SWS DCF valuations with cash flow stories that could be just as interesting. Use Simply Wall St to analyze and filter these results by the specific catalysts and narratives that matter to you, so you can identify the opportunities that are most relevant for your watchlist.

Take Control of Your Investment Journey

If Taiyo Yuden or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Today?

Some of the most interesting breakout stories start flying before the crowd notices, then momentum fades once they are fully priced. Scan fresh, under the radar ideas now and consider them while they remain less widely followed.

• Spot potential early movers by reviewing hand picked 57 high quality undiscovered gems that pair solid financials with stories the broader market has not fully caught yet.
• Target resilient performers by scanning the curated 49 resilient stocks with low risk scores that focuses on businesses built to hold up when sentiment drops and volatility increases.
• Follow structural trends by assessing a focused set of 34 power grid technology and infrastructure stocks tied to the next phase of electrification before these stories move more fully into the spotlight.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.